Frazier Healthcare Partners — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
BrightSpring Health Services operates complementary home and community-based health services for complex populations requiring specialized or chronic care, including home health, hospice, senior care, and pharmacy management across all 50 U.S. states.
Digital HealthHealthtechWellness & Fitness
Jennifer Yowler(President, PharMerica)Mike McMaude(President, Home Health and Hospice Services)Jim Mattingly(Executive Vice President and Chief Financial Officer)inLisa Nalley(Chief of Staff and Senior Vice President, Human Resources)inJon Rousseau(Chairman, President, and Chief Executive Officer)inBob Barnes(President, Community Living)
Co-investorsEpsilon Health Investors
Maze Therapeutics develops precision medicines for common diseases with high unmet need, using its Compass platform based on human genetics and variant functionalization.
AI & Machine LearningBiotechSouth San Francisco, US
Charles Homcy(Director)Jason Coloma(Chief Executive Officer)in
Co-investorsAndreessen HorowitzARCH Venture PartnersForesite CapitalFrazier Life SciencesGV (Google Ventures)Janus Henderson Investors+3 more
Healthcare company acquired by Mirum Pharmaceuticals, a former RiverVest portfolio company.
San Mateo, US
Keting Chu(Executive Officer, Director)inDajun Yang(Director)Nancy Hong(Director)inAlon Lazarus(Director)William J. Rutter(Director)Ting Jia(Director)
Co-investorsFrazier Life SciencesRA CapitalRiverVest Venture PartnersHBM Healthcare InvestmentsNovo HoldingsT. Rowe Price+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.